{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-064650","form_type":"8-K","ticker":"ISPC","cik":"0001558569","company_name":"iSpecimen Inc.","filed_at":"2023-05-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.380062+00:00","generated_at":"2026-06-14T14:30:19.267974+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"iSpecimen shareholders approve plan amendment increasing share reserve 3x to 1.87M","bullets":["Stockholders approved amendment to 2021 plan: shares reserved increased from 608,000 to 1,869,500 shares.","Annual automatic share increase mechanism removed; clawback/recoupment provision added.","Three Class II directors (Brooks, Curley, Mock) elected to three-year terms.","Proposal to allow director removal without cause failed (3.8M for vs required majority of outstanding shares).","Ratification of Wolf & Company as auditor for FY2023 approved (6,421,007 for)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-064650","json":"https://secwatch.observer/filing/0001104659-23-064650.json","markdown":"https://secwatch.observer/filing/0001104659-23-064650.md","text":"https://secwatch.observer/filing/0001104659-23-064650.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923064650/0001104659-23-064650-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923064650/tm2316924d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T14:30:19.267974+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"407f4952decb35888df404fe0597da09eddcaaa8","claim":"iSpecimen Inc. shareholders approved Approval of an amendment to the Second A&R 2021 Plan to increase the number of shares reserved for issuance from 608,000 to 1,869,500 shares.","evidence_excerpt":"Proposal No. 3 was approved by a majority of the votes cast.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923064650/0001104659-23-064650-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"50a0c8c2beae2fbbe830499f12e41bf819508012","claim":"iSpecimen Inc. shareholders approved Approval of amendments to the Second A&R 2021 Plan to remove automatic annual increase and add clawback provisions.","evidence_excerpt":"Proposal No. 2 was approved by a majority of the votes cast.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923064650/0001104659-23-064650-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"68f6cef1408caa10f3c51488868c028dc1ecaf0e","claim":"iSpecimen Inc. shareholders approved Election of three Class II directors each to serve for a three-year term that expires at the 2026 annual meeting of stockholders.","evidence_excerpt":"Brooks III 3,900,970 704,582 1,914,191 Tracy Curley 4,056,320 549,232 1,914,191 Theresa L. Mock 4,412,763 192,789 1,914,191 Each nominee was elected.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923064650/0001104659-23-064650-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"88c8e0a3b86deeee629604295a8c0e14b31ebd75","claim":"iSpecimen Inc. shareholders approved Ratification of appointment of Wolf & Company, P.C. as independent registered public accounting firm for the year ending December 31, 2023.","evidence_excerpt":"Proposal No. 5 was approved by a majority of the votes cast.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923064650/0001104659-23-064650-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"ca4f8babc9693cba6154cfc02fb8781451abb8ae","claim":"iSpecimen Inc. shareholders rejected Approval of an amendment to the Fourth Amended and Restated Certificate of Incorporation to permit removal of directors by stockholders without cause.","evidence_excerpt":"Proposal No. 4 was not approved, because votes in favor of this proposal did not represent a majority of the voting shares entitled to vote thereon, as required.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923064650/0001104659-23-064650-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"failed"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}